Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/45874
Tipo
PreprintDerechos de autor
Acceso abierto
Colecciones
- MG - IRR - Preprint [13]
Metadatos
Mostrar el registro completo del ítem
CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS HOSPITALIZED WITH COVID-19 IN BRAZIL: RESULTS FROM THE BRAZILIAN COVID-19 REGISTRY
SARS-CoV-2
Hospitalizações
Pandemia
Brazil
Mortality
Disease progression
SARS-CoV-2
Hospitalizations
Pandemic
Mortalidade
Doenças progressivas
Autor
Afiliación
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Center for Research and Graduate Studies in Business Administration, Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal de São João del-Rey. Divinópolis, MG, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil
Vall d’Hebron University Hospital, PROSICS Barcelona. Barcelona, Spain / Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Center for Research and Graduate Studies in Business Administration, Belo Horizonte, MG, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal de São João del-Rey. Divinópolis, MG, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil.
Universidade Federal de Minas Gerais. Medical School and University Hospital. Belo Horizonte, MG, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil
Vall d’Hebron University Hospital, PROSICS Barcelona. Barcelona, Spain / Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brazil.
Universidade Federal do Rio Grande do Sul. Institute for Health Technology Assessment. Porto Alegre, RS, Brazil.
Resumen en ingles
Objectives: To describe clinical characteristics, laboratory and imaging findings, as well as in-hospital outcomes of COVID-19 patients admitted to Brazilian hospitals. Methods: Cohort study of laboratory-confirmed COVID-19 patients hospitalized from March to September 2020 at 25 hospitals. Study data were collected from medical records using Research Electronic Data Capture (REDCap) tools. Multivariate Poisson regression model was used to assess risk factors for in-hospital mortality. Results: Of 2054 patients (52.6% male, median age 58 years old), in-hospital mortality was 22.0%, and 47.6% among those treated in the ICU. Hypertension (52.9%), diabetes (29.2%) and obesity (17.2%) were the most prevalent comorbidities. Overall, 32.5% required invasive mechanical ventilation and 12.1% kidney replacement therapy. Septic shock was observed in 15.0%, nosocomial infection in 13.1%, thromboembolism in 4.1% and acute heart failure in 3.6%. Age ≥65 years-old, chronic kidney disease, hypertension, C-reactive protein ≥100 mg/dL, platelet count <100 × 109/L, oxygen saturation <90%, supplementary oxygen requirement and invasive mechanical ventilation at admission were independently associated with a higher risk of in-hospital mortality. The overall use of antimicrobials was 87.9%. Conclusions: This study provides characteristics and in-hospital outcomes of consecutively hospitalized patients with confirmed COVID-19 in Brazil. Easily assessed parameters at hospital admission were independently associated with a higher risk of death. The high frequency of antibiotic use points to an over-use of antimicrobials in COVID-19 patients.
Palabras clave en portugues
COVID-19SARS-CoV-2
Hospitalizações
Pandemia
Brazil
Mortality
Disease progression
Palabras clave en ingles
COVID-19SARS-CoV-2
Hospitalizations
Pandemic
Mortalidade
Doenças progressivas
Compartir